INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 143 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2016. The put-call ratio across all filers is 1.43 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $56,000 | +19.1% | 7,766 | 0.0% | 0.02% | +13.6% |
| Q1 2018 | $47,000 | -37.3% | 7,766 | 0.0% | 0.02% | -33.3% |
| Q4 2017 | $75,000 | -11.8% | 7,766 | -18.4% | 0.03% | -21.4% |
| Q3 2017 | $85,000 | -41.8% | 9,516 | -17.4% | 0.04% | -44.0% |
| Q2 2017 | $146,000 | +0.7% | 11,516 | -16.3% | 0.08% | -1.3% |
| Q1 2017 | $145,000 | +14.2% | 13,766 | 0.0% | 0.08% | +13.4% |
| Q4 2016 | $127,000 | +202.4% | 13,766 | +288.3% | 0.07% | +191.3% |
| Q3 2016 | $42,000 | -8.7% | 3,545 | 0.0% | 0.02% | -11.5% |
| Q2 2016 | $46,000 | -17.9% | 3,545 | +0.4% | 0.03% | -16.1% |
| Q1 2016 | $56,000 | -44.0% | 3,530 | +0.9% | 0.03% | -44.6% |
| Q4 2015 | $100,000 | 0.0% | 3,500 | 0.0% | 0.06% | -6.7% |
| Q3 2015 | $100,000 | -20.6% | 3,500 | 0.0% | 0.06% | -16.7% |
| Q2 2015 | $126,000 | +23.5% | 3,500 | +100.0% | 0.07% | +12.5% |
| Q1 2015 | $102,000 | +500.0% | 1,750 | +322.7% | 0.06% | +481.8% |
| Q4 2014 | $17,000 | – | 414 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 5,406,844 | $52,014,000 | 0.66% |
| ETF MANAGERS GROUP, LLC | 282,268 | $3,255,000 | 0.24% |
| Mirae Asset Global Investments Co., Ltd. | 1,470,996 | $14,151,000 | 0.19% |
| Financial Gravity Companies, Inc. | 4,467 | $42,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 67,200 | $646,000 | 0.04% |
| TCI Wealth Advisors, Inc. | 7,766 | $75,000 | 0.03% |
| Freedom Investment Management, Inc. | 64,741 | $623,000 | 0.03% |
| GAM Holding AG | 83,940 | $808,000 | 0.02% |
| SFMG, LLC | 11,994 | $115,000 | 0.02% |
| SHELL ASSET MANAGEMENT CO | 95,127 | $915,000 | 0.02% |